# Molina Healthcare, Inc.: Form 10-Q for the period ended Mar 31, 2023

- Company: [Molina Healthcare, Inc.](/companies/moh.md) (CIK 1179929)
- Form: 10-Q
- Filed: 2023-04-27
- Accepted by EDGAR: Apr 27, 2023, 10:51 ET
- Period: 2023-03-31
- Accession: 0001179929-23-000069
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1179929/000117992923000069/moh-20230331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1179929/000117992923000069/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2023-01-01 to 2023-03-31 | $8.15bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2023-01-01 to 2023-03-31 | $6.87bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months, 2023-01-01 to 2023-03-31 | $455.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2023-01-01 to 2023-03-31 | $28.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2023-01-01 to 2023-03-31 | $106.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2023-01-01 to 2023-03-31 | $321.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2023-01-01 to 2023-03-31 | $5.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2023-01-01 to 2023-03-31 | $5.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2023-01-01 to 2023-03-31 | 58,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2023-01-01 to 2023-03-31 | $916.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2023-01-01 to 2023-03-31 | $32.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2023-03-31 | $4.55bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-03-31 | $11.16bn | us-gaap:AssetsCurrent |
| Total assets | at 2023-03-31 | $13.37bn | us-gaap:Assets |
| Current liabilities | at 2023-03-31 | $7.61bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-03-31 | $10.08bn | us-gaap:Liabilities |
| Long-term debt | at 2023-03-31 | $2.18bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2023-03-31 | $3.29bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1179929/000117992923000069/moh-20230331.htm

Filed Apr 27, 2023.
Source: SEC EDGAR, the filing index for accession 0001179929-23-000069. Last ingested by Listed: Nov 11, 2026, 00:18 ET. No prices; not investment advice.